Clinical Trial Update: High Dose Candesartan Versus Quinapril for Restenosis Prophylaxis After Stent Angioplasty [NA]

View source ↗

Summary

A completed clinical trial sponsored by Technische Universität Dresden compared high-dose candesartan with quinapril for restenosis prophylaxis after stent angi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Peripheral Artery Disease

Drugs mentioned

• Candesartan (candesartan)
• Quinapril (quinapril)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Arterial Occlusive Diseases | NA | Status: COMPLETED